GE HealthCare Q3 2026 net income attributable to company jumps 38% year over year to $615 million
Bitget2026/10/28 10:21- GE HealthCare third-quarter 2026 diluted EPS rose 39% to $1.36, while revenues increased 7% to $5.51 billion.
- Cash flow from operating activities climbed 53% to $907 million, including a $55 million tariff refund.
- The planned $945 million cash acquisition of SOFIE Biosciences is expected to close in the first half of 2027, pending approvals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.